(Press-News.org) An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof. Patrice Cani (Imperial & University of Louvain, UCLouvain), Dr. Dominique Gauguier (Imperial & INSERM, Paris) and Prof. Peter Liu (University of Ottawa Heart Institute) has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published in Nature Metabolism, the study reveals that TMA, produced by gut bacteria from dietary choline can block a key immune pathway and improve blood sugar control.
This major breakthrough has its roots 20 years earlier. During his postdoctoral research, Patrice Cani discovered that a high-fat diet leads to the presence of bacterial components in the body, which activates the immune system and triggers inflammation, eventually causing insulin resistance in diabetic individuals. Considered far-fetched in 2005, this finding is now well established and widely accepted by scientists.
In 2025, researchers from University of Louvain and Imperial College London finally uncovered how to counter this process. They observed that TMA, produced by gut bacteria from a natural nutrient, dietary choline, found in certain foods can improve blood-sugar control.
How? By acting as a natural inhibitor of the protein IRAK4, a key component of the immune system. Normally, when exposed to a high-fat diet, IRAK4 sounds the alarm and triggers inflammation to signal dietary imbalance.
The problem? With constant overload (as seen in type 2 diabetes), IRAK4 overreacts, causing cascading inflammation that drives insulin resistance.
By combining human cell models, mouse studies, and molecular-target screening, scientists discovered that TMA can bind directly to IRAK4 and block its activity. The direct effect is a reduction in fat-induced inflammation and a restoration of insulin sensitivity. In essence, it reprograms the negative metabolic responses caused by poor diet. Even more striking: the molecule can prevent sepsis-induced mortality in mice by blocking widespread inflammation.
“This shows how nutrition and our gut microbes can work together by producing molecules that fight inflammation and improve metabolic health!”, said Prof. Patrice Cani, co-senior author, University of Louvain, Belgium and visiting professor at Imperial College London.
The team also observed that genetically deleting IRAK4 or blocking it pharmacologically reproduced the beneficial effects of the bacterial metabolite. This opens new therapeutic avenues for diabetes, using a target, IRAK4, that is already validated within the pharmaceutical industry.
“This flips the narrative,” said Prof. Dumas. “We’ve shown that a molecule from our gut microbes can actually protect against the harmful effects of a poor diet through a new mechanism. It’s a new way of thinking about how the microbiome influences our health.”
“This shows how nutrition and our gut microbes can work together by producing molecules that fight inflammation and improve metabolic health!”, said Prof. Patrice Cani, co-senior author, University of Louvain, Belgium and visiting professor at Imperial College London.
Major implications
With more than 500 million people worldwide affected by diabetes, identifying TMA as a microbial signal that modulates immunity could pave the way for new treatments. Nutritional strategies or drugs designed to boost TMA production may offer a new approach to combating insulin resistance and its complications.
“What we eat shapes our microbes and some of their molecules can protect us from diabetes. That’s nutrition in action!” said University of Louvain, Prof. Cani.
This research was made possible thanks to international collaborations across Europe and North America, involving institutions in Belgium, Canada, Australia, France, Italy, and Spain, and supported by numerous European (ERC, FEDER) and national (MRC, Wellcome Trust, ANR, FNRS, EOS, WELRi, ARC) funding sources.
END
Major breakthrough against diabetes thanks to a microbial molecule that disarms inflammation
2025-12-08
ELSE PRESS RELEASES FROM THIS DATE:
Silicon chips on the brain: Researchers announce a new generation of brain-computer interface
2025-12-08
A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and blindness – helping to manage seizures and restore motor, speech, and visual function. This is done by providing a minimally invasive, high-throughput information link directly to and from the brain.
The transformational potential of this new system lies in its small size and ability to transfer data at high rates. Developed by researchers at Columbia University, NewYork-Presbyterian Hospital, Stanford University, and the University of Pennsylvania, this brain-computer interface (BCI) relies ...
Getting rest is the best
2025-12-08
Getting enough sleep and staying active are two of the most important things we can do for our health, but new research shows that most people struggle to achieve both, and that sleep may hold the key to moving more.
A study led by Flinders University analysed more than 28 million days of real-world health data from over 70,000 people across the globe and found that fewer than 13% consistently meet recommended sleep and physical activity targets.
The findings suggest that improving sleep quality could be an effective way to boost daily activity.
The research team examined data collected over three ...
Towards sustainable organic synthesis – Mechanochemistry replaces lithium with sodium in organic reactions
2025-12-08
Highly reactive organometallic reagents, like organolithiums (molecules with a carbon–lithium bond) are essential reagents in organic synthesis because of their applications from polymer synthesis to pharmaceuticals, and more. Lithium resources, however, are difficult to access because concentrated deposits are geographically restricted and modern extraction methods are burdened with environmental costs. Replacing lithium with sodium would be a significant contribution towards environmentally friendly organic synthesis because it is >1000 times more abundant and its extraction from seawater is sustainable ...
Wireless device ‘speaks’ to the brain with light
2025-12-08
In a new leap for neurobiology and bioelectronics, Northwestern University scientists have developed a wireless device that uses light to send information directly to the brain — bypassing the body’s natural sensory pathways.
The soft, flexible device sits under the scalp but on top of the skull, where it delivers precise patterns of light through the bone to activate neurons across the cortex.
In experiments, scientists used the device’s tiny, patterned bursts of light to activate specific populations of neurons deep inside the brains of mouse models. (These neurons are genetically modified to respond to light.) The mice quickly learned ...
Greenhouse gases to intensify extreme flooding in the Central Himalayas
2025-12-08
Rising greenhouse gas emissions could see the size of extreme floods in the Central Himalayas increase by between as much as 73% and 84% by the end of this century.
Geographers at Durham University, UK, simulated the risk of increased flooding on the Karnali River, which spans Nepal and China and has the potential to impact communities in Nepal and India.
They found that extreme floods – those with a 1% chance of happening within a year – could increase in size by 22% and 26% between 2020 and 2059, compared to flooding seen in the region between 1975 and 2014.
This increase ...
New study sheds light on Milky Way's mysterious chemical history
2025-12-08
Clues about how galaxies like our Milky Way form and evolve and why their stars show surprising chemical patterns have been revealed by a new study.
The research, published today in Monthly Notices of the Royal Astronomical Society, explores the origins of a puzzling feature in the Milky Way: the presence of two distinct groups of stars with different chemical compositions, known as the "chemical bimodality".
When scientists study stars near the Sun, they find two main types based on their chemical makeup, specifically, the amounts of iron (Fe) and magnesium (Mg) they contain. These two groups form ...
Could altering the daily timing of immunotherapy improve survival in people with cancer?
2025-12-08
Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That’s according to a study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
An internal clock, or circadian rhythm, affects when different physiological processes (including immune reactions) in the body are active. This might explain why various medications appear to be more effective when taken at certain times of day.
Researchers investigated this phenomenon in 397 patients with extensive-stage small cell lung cancer who received the immunotherapy drugs atezolizumab or durvalumab plus chemotherapy at the ...
Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance
2025-12-08
A joint research team led by Dr. Gyujin Song of the Korea Institute of Energy Research (President: Yi, Chang-Keun, hereafter “KIER”), Dr. Kwon-Hyung Lee of the University of Cambridge, and Professor Tae-Hee Kim of the University of Ulsan has successfully developed a new dry-process manufacturing technology for secondary battery electrodes that overcomes the limitations of conventional electrode fabrication processes.
The technology developed by the research team is a dry manufacturing process that forms ...
Using social media may impair children’s attention
2025-12-08
Children who spend a significant amount of time on social media tend to experience a gradual decline in their ability to concentrate. This is according to a comprehensive study from Karolinska Institutet, published in Pediatrics Open Science, where researchers followed more than 8,000 children from around age 10 through age 14.
The use of screens and digital media has risen sharply in the past 15 years, coinciding with an increase in ADHD diagnoses in Sweden and elsewhere. Researchers at Karolinska Institutet in Sweden and Oregon Health ...
Science briefing: An update on GLP-1 drugs for obesity
2025-12-08
In a special 11 December event for science journalists, the Science Press Package team will revisit the topic recognized as Science’s Breakthrough of the year in 2023: the development of GLP-1 receptor agonists to treat obesity and their efficacy in blunting obesity-associated health problems. The Mani L. Bhaumik Breakthrough of the Year Award that the American Association for the Advancement of Science, publisher of Science, gave to researchers whose work best underpinned ...